Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04768647 · ClinicalTrials.gov registry record · Phase 1

Vestibulopathy as a Cause of Imbalance in Parkinson

A Phase 1 study, sponsored by VA Office of Research and Development.

Completed
Registry status
Phase 1
Development phase
60
Enrollment target

NCT04768647: Completed Phase 1 study, sponsored by VA Office of Research and Development.

NCT04768647 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 60 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04768647, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
Phase 1
Development phase
60 participants
Enrollment target

Study Summary

Balance problems and falls are common in people with Parkinson's disease but respond poorly to dopamine stimulating medications suggesting other causes. The main goal of this study is to assess whether imbalance and gait problems in people with Parkinson's disease may be related to vestibular (inner ear balance center) changes not related to loss of dopamine in the brain.

Primary Outcome

Assessment of vestibular functions using standard vestibular testing

Interventions

  • DEVICE TNM

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-05-28
Est. Completion 2025-10-30
Phase Phase 1
VA Office of Research and Development

1,668 total trials

What the finished NCT04768647 record still lists

NCT04768647 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.

The record links to 0 conditions, and to 1 intervention - of which TNM is the first listed.

NCT04768647 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04768647 about?

NCT04768647 is a clinical study titled "Vestibulopathy as a Cause of Imbalance in Parkinson". Balance problems and falls are common in people with Parkinson's disease but respond poorly to dopamine stimulating medications suggesting other causes. The main goal of this study is to assess whether imbalance and gait problems in people with Parkinson's disease may be related to vestibular (inner...

What is the current status of trial NCT04768647?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2021-05-28. Estimated completion is 2025-10-30.

What interventions are being tested in trial NCT04768647?

The interventions under investigation include: TNM (DEVICE).

Who is sponsoring clinical trial NCT04768647?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04768647's enrollment target sits among peer trials

60 831st of 2000 higher than 1,106 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04768647, the US trial registry maintained by the National Library of Medicine. NCT04768647 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.